This bill requires the Secretary of Veterans Affairs to run a three-year pilot program that furnishes hyperbaric oxygen therapy (HBOT) to veterans diagnosed with traumatic brain injury (TBI) or post‑traumatic stress disorder (PTSD) through community-care providers identified in 38 U.S.C. 1703(c)(5). The pilot will operate in two selected Veterans Integrated Service Networks (VISNs), limit participating facilities to those with specific accreditations, and define HBOT to include devices that are FDA-approved or operating under an investigational device exemption (IDE).
Instead of new appropriations, the bill creates a VA HBOT Fund that may receive only donated money to pay for the pilot and makes those funds available without fiscal year limitation; both the fund and the pilot terminate three years after enactment. The bill also directs the Comptroller General to update a 2015 GAO report on HBOT clinical trials within one year and extends a pension payment limit in 38 U.S.C. section 5503(d)(7) to October 30, 2034.
The structure raises practical questions about evidence generation, equitable access, and donor-driven program design that stakeholders will need to address during implementation.
At a Glance
What It Does
Creates a VA pilot delivering HBOT to veterans with TBI or PTSD through community providers in two VISNs, requires facility accreditation, defines eligible HBOT devices (FDA‑approved or IDE), and funds the pilot solely with donated money placed in a VA HBOT Fund available without fiscal‑year limits. Also orders a GAO update on HBOT research and extends a pension payment deadline in title 38.
Who It Affects
Veterans eligible for VA community care under 38 U.S.C. 1703(c)(5), VA medical centers and two selected VISNs, accredited hyperbaric clinics that seek VA referrals, the Comptroller General and researchers reviewing HBOT trials, and private donors providing funds for the pilot.
Why It Matters
The bill tests delivering a contested therapy through VA's community‑care channel rather than internal VA facilities, ties program scale to voluntary donations rather than appropriations, and compels an updated federal synthesis of HBOT evidence—actions that could shape future VA treatment policy if the pilot produces actionable data.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill directs the VA to stand up a narrowly scoped, three‑year pilot to provide hyperbaric oxygen therapy to veterans diagnosed with traumatic brain injury or post‑traumatic stress disorder. Instead of expanding coverage across the system, the VA must pick two VISNs to host the effort and rely on community‑care providers eligible under 38 U.S.C. 1703(c)(5) to actually deliver treatments.
The law limits participating sites to facilities accredited by the Joint Commission, the Undersea and Hyperbaric Medical Society (UHMS), or an equivalent objective accreditor.
Financially, Congress does not appropriate money for operations; the bill sets up a VA HBOT Fund into which the Secretary may deposit only donations earmarked for the pilot. Those donated sums are available without fiscal year limitation, which lets the VA spend received donations across years but also means program scale depends entirely on private giving.
The statute defines HBOT as therapy delivered with either an FDA‑approved device or a device operating under an FDA investigational device exemption (IDE), allowing investigational treatments to be used within the pilot framework.Oversight and evidence collection are modestly addressed. The Comptroller General must provide an updated assessment within one year of the bill's enactment that reviews clinical trials of HBOT for TBI and PTSD completed since 2015, including trials by the VA, Department of Defense, and private actors.
The bill does not, however, require the VA to publish structured outcome or utilization reports for the pilot itself, nor does it stipulate patient eligibility criteria, enrollment targets, or specific data‑collection protocols. Finally, the bill amends 38 U.S.C. 5503(d)(7) to extend a pension payment limit deadline to October 30, 2034, a separate fiscal timing change inserted at the end of the measure.
The Five Things You Need to Know
The pilot is limited to two Veterans Integrated Service Networks (VISNs); the VA chooses which VISNs will operate the program.
Participating HBOT sites must hold accreditation from the Joint Commission, the Undersea and Hyperbaric Medical Society, or an equivalent accreditor.
The VA HBOT Fund is the sole permitted source of money for the pilot and may receive only donations specifically designated for the program; those funds are available without fiscal‑year limitation.
The bill allows HBOT to be provided using either an FDA‑approved device or a device operating under an FDA investigational device exemption (IDE), explicitly permitting investigational devices.
Within one year, the Government Accountability Office must update its 2015 report to assess clinical trials of HBOT for TBI and PTSD conducted by VA, DoD, and private entities; separately, the bill extends the deadline in 38 U.S.C. 5503(d)(7) to October 30, 2034.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title — Veterans National Traumatic Brain Injury Treatment Act
A single sentence gives the act its public name. This is purely stylistic but identifies the bill's focus on traumatic brain injury care and signals the framers' intent to treat TBI as the central clinical target while including PTSD in the operative language that follows.
Pilot structure, eligible providers, and accreditation requirements
Subsections (a) and (b) require the VA to implement a pilot furnishing HBOT to veterans with TBI or PTSD via providers covered under 38 U.S.C. 1703(c)(5) and to confine operations to two VISNs. That citation refers to community‑care providers the VA may contract with, so the pilot runs through the community‑care channel rather than obligating care inside VA hospitals. Subsection (c) forces a minimum quality standard by requiring participating facilities to be accredited by the Joint Commission, UHMS, or a comparable objective organization, which sets a clear bar for clinical operations but may exclude smaller or newer hyperbaric centers that lack those accreditations.
Donation‑only funding, fund availability, device definition, and sunset
The bill creates a VA HBOT Fund in the Treasury and specifies that donations are the sole source of deposits; no appropriations are authorized. The statute allows those donated amounts to be used without fiscal‑year limitation, so funds can carry over across years, but program financing is entirely dependent on voluntary giving. Subsection (f) defines HBOT to include treatments using FDA‑approved devices or devices operating under IDEs, which permits investigational device use within the pilot. Finally, the pilot and the Fund automatically terminate three years after enactment, creating a strict window for implementation and evaluation.
GAO evidence update and pension payment deadline extension
Section 3 directs the Comptroller General to deliver an updated review—building on GAO–16‑154—of clinical trials conducted since 2015 involving HBOT for TBI and PTSD, specifically covering studies by the VA, DoD, and private entities. That update creates an independent evidence synthesis obligation but does not require VA to use that analysis to change coverage. Section 4 is a technical amendment that extends a statutory date in 38 U.S.C. 5503(d)(7) from November 30, 2031, to October 30, 2034; it does not alter the pilot but affects timing for limits on certain pension payments.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans with TBI or PTSD seeking additional treatment options—The pilot creates a pathway to access HBOT through VA community care in selected VISNs, potentially expanding treatment choices for individuals who have not benefited from standard therapies.
- Accredited hyperbaric clinics that meet VA community‑care contracting requirements—Those facilities may gain new revenue streams and veteran referrals if they secure contracts and the necessary accreditations.
- Researchers and policymakers—The GAO update and any program data collected (even if limited) provide additional synthesis and potentially new data points on HBOT's clinical effects that could inform future VA policy.
Who Bears the Cost
- The Department of Veterans Affairs—VA must design, administer, and oversee the pilot, handle donated funds, vet and contract with community providers, and manage patient referrals and safety oversight without new appropriated funding for operations.
- Selected VISNs and local VA staff—Operational burdens fall on the two VISNs chosen to host the pilot, which must absorb coordination, case management, and quality assurance tasks within existing budgets.
- Community hyperbaric providers without current accreditations—Clinics that want to participate may need to invest in accreditation, facility upgrades, or compliance systems to meet the bill's required standards.
- Private donors and foundations—Because donations are the only authorized funding source, donors effectively underwrite the pilot; they assume financial risk and potential reputational exposure if outcomes prove unfavorable or access is uneven.
Key Issues
The Core Tension
The central dilemma is whether to increase veteran access to a controversial therapy now—by using community providers, investigational devices, and donor dollars—or to require stronger, VA‑led evidence generation and budgetary commitment before expanding HBOT; the bill opts for access and experimentation but provides limited statutory guardrails for evidence quality, equity of access, and donor influence.
The bill creates a tension between expanding access and ensuring rigorous evidence: it authorizes delivery of HBOT (including investigational devices) while offering no statutory requirements for enrollment criteria, standardized outcome measures, or VA‑managed data collection tied to the pilot. That gap means the program could deliver care without producing the kind of high‑quality evidence that payers and clinicians need to assess HBOT's effectiveness for TBI or PTSD.
Relying exclusively on donated funds is another double‑edged sword. It enables the pilot without a discretionary appropriation but makes program scale and continuity contingent on private giving, which can be unpredictable and raise governance questions about donor priorities.
Restricting operations to two VISNs and requiring high‑level accreditations narrows the pilot’s footprint and may skew results if the selected VISNs or accredited centers serve atypical patient populations. Finally, allowing IDE devices expands therapeutic options but increases the need for informed consent and safety oversight; the statute does not set out IRB, consent, or adverse‑event reporting standards specific to this pilot, which leaves operational design to the Secretary and creates legal and clinical risk that will have to be managed in implementation.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.